Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials

per Aletaha, D
Publicat 2006

Authors' reply

per Aletaha, D, Smolen, J
Publicat 2003

Patients with rheumatoid arthritis in clinical care

per Smolen, J, Aletaha, D
Publicat 2004

Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis

per Aletaha, D, Kapral, T, Smolen, J
Publicat 2003

Step‐up combination versus switching of non‐biological disease‐modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study

per Schoels, M, Kapral, T, Stamm, T, Smolen, J S, Aletaha, D
Publicat 2007

Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition

per Schoels, M., Alasti, F., Smolen, J. S., Aletaha, D.
Publicat a Arthritis Res Ther (2017)

Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years

per Aletaha, D, Eberl, G, Nell, V, Machold, K, Smolen, J
Publicat 2002

Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey

per Aletaha, D, Eberl, G, Nell, V, Machold, K, Smolen, J
Publicat 2004

Perception of Improvement in Patients With Rheumatoid Arthritis Varies With Disease Activity Levels at Baseline

per ALETAHA, D., FUNOVITS, J., WARD, M. M., SMOLEN, J. S., KVIEN, T. K.
Publicat 2009

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis...

per Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, Garg V
Publicat 2017-07-01

Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study

per Aletaha, D, Stamm, T, Kapral, T, Eberl, G, Grisar, J, Machold, K, Smolen, J
Publicat 2003

Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis

per Gärtner, M, Sigmund, I K, Alasti, F, Supp, G, Radner, H, Machold, K, Smolen, J S, Aletaha, D
Publicat a RMD Open (2016)

Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data

per Dougados, M, Schmidely, N, Le Bars, M, Lafosse, C, Schiff, M, Smolen, J S, Aletaha, D, van Riel, P, Wells, G
Publicat 2008

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patien...

per Wells, G, Becker, J-C, Teng, J, Dougados, M, Schiff, M, Smolen, J, Aletaha, D, van Riel, P L C M
Publicat 2008

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and...

per Machado, P, Castrejon, I, Katchamart, W, Koevoets, R, Kuriya, B, Schoels, M, Silva-Fernández, L, Thevissen, K, Vercoutere, W, Villeneuve, E, Aletaha, D, Carmona, L, Landewé, R, van der Heijde, D, Bijlsma, J W J, Bykerk, V, Canhão, H, Catrina, A I, Durez, P, Edwards, C J, Mjaavatten, M D, Leeb, B F, Losada, B, Martín-Mola, E M, Martinez-Osuna, P, Montecucco, C, Müller-Ladner, U, Østergaard, M, Sheane, B, Xavier, R M, Zochling, J, Bombardier, C
Publicat 2010